1.gif (1892 bytes)

Case Reports

Indian Pediatrics 2001; 38: 788-791  

Langherhans Cell Histiocytosis in Monozygotic Twins


Archana B. Patel,
Ramesh L. Renge

From the Department of Pediatrics, Indira Gandhi Medical College, Nagpur, India.
Correspondence to: Dr. Archana B. Patel, 125, Raj Nagar, Opposite Tidke Vidyalaya, Katol Road, Nagpur 440 013, MS, India.E-Mail: [email protected]

Manuscript received: September 25, 2000; Initial review completed: October 31, 2000;
Revision accepted: January 25, 2001.

Histiocytosis are a heterogenous group of disorders that are characterized by prolifera-tion and activation of mononuclear phagocyte system. Langerhans Cell Histiocytosis (LCH) or Class I histiocytosis is a rare disorder of unknown etiology with proliferation of Langerhan cells which may infiltrate a single or multiple organs. This disease is more common in infants and children. It is usually sporadic but a familial pattern is known. We are presenting a case of LCH in monozygotic twins which is an exceptional manifestation of this rare disease.

Case Report

Four-year-old monozygotic female twins were brought to our hospital with nodular swellings over the scalp and generalized lymphadenopathy since 6 weeks. They were afebrile, pale and had hepatosplenomegaly. Both had nodular lesions over the scalp and one also had supraorbital lesion (Fig. 1). There was no jaundice, petechiae, ecchymosis or joint swellings. Other systems were normal.

The laboratory and radiographic investiga-tions in both children were similar. Their hemoglobin was 7 g/dl. The abdominal sono-graphy revealed hepatosplenomegaly. The skull radiograph showed multiple punched out lesions (Fig. 2). The radiography of long bones and chest were normal. The peripheral smear showed normocytic normochromic anemia with normal platelet counts and no blasts. The urine analysis, coagulation profile, bone marrow, renal and liver function tests were normal. The fine needle aspiration cytology (FNAC) and biopsy of cervical lymph node showed numerous uni, bi, and multinucleated histiocytes in the background of numerous eosinophils and lymphocytes suggestive of LCH.

They were treated with Inj. Vinblastine 6 mg/m2, Tab. Prednisolone 40 mg/m2 and Tab. Endoxan 200 mg/m2 during induction phase(1). The patients are on maintenance therapy of Inj. Vinblastine 6 mg/m2 and Tab. Prednisolone. The anemia, lymphadenopathy and hepatosplenomegaly responded to treat-ment. There was shrinking of the skull lesions on radiography within 6 months of therapy.

Fig. 1. Multinodular scalp swelling in monozygotic twins.

Fig. 2. X-ray skull showing multiple osteolytic shadows.

Discussion

Recently, histiocytosis has been classified into three classes(2). Class I and Class II are non-malignant whereas Class III is malignant. Our patients had classical manifestations of Class I or Langerhans’s cell histiocytosis in the form of multiple osteolytic lesions, lymph-adenopathy and hepatosplenomegaly without organ dysfuction. Children with organ dys-function have a higher mortality as compared to children with multiple organ involvement without dysfunction(1).

LCH is a rare disease of unknown etiology. Its presentation in families particularly in twins is even less frequent. In 1952, the first concrete suggestion of genetic influence was a report on Letterer-Siwe disease in uniovular twins (3). Subsequently there have been a few reports of histiocytosis in twins(4-10). The histiocytosis was disseminated in five of these reported cases with poor response to treatment and fatality in three(6,9,10). Disseminated histio-cytosis in twins with similar clinical presenta-tion as ours has been reported earlier(4). They also had simultaneous onset of disease, almost identical clinical follow-up and findings on cranial CT. Our patients were responsive to treatment.

There has been no satisfactory explanation why LCH occurs in twins. Although, it is considered to be non-hereditary, reports indicate otherwise. A survey was conducted to identify familial LCH cases (11). Nine families had more than one affected relative: five with LCH-concordant twin pairs (four were presumed monozygotic twins) and four with LCH in siblings or cousins. Another indication for genetic propensity is the occurrence of LCH in family with Hodgkins’ lymphoma. Hodgkin’s lymphoma was diagnosed in the father and the latter’s maternal uncle in one of the reported cases of LCH in twin sisters(5). Genetic susceptibility has also been suggested in Hodgkin’s disease. Monozygotic twins of patients with Hodgkin’s have been reported to have a greatly increased risk for the disease as compared to dizygotic twins. Genetic suscepti-bility also underlies Hodgkin’s disease in young adulthood(7). It is possible that a similar genetic propensity may underlie LCH. This genetic predisposition would become clearer if more cases are reported and chromosomal work-up of the families are obtained.

An atypical immumological reaction has also been postulated as an underlying cause of this disease(12). Cytokines as an endogenous signal that may trigger the pathologic proliferation of Langerhans cells has also been suggested(9).

Various treatment modalities have been used. The twins that were first reported in 1952 were treated with antibiotics and remained without evidence of disease 17 years later(3). Treatment modalities used nowadays are chemotherapy, radiotherapy and surgery for localized lesions. Various chemotherapeutic agents used are vinblastine, etoposide, metho-trexate, vincristine, cyclophosphamide, 6 mercatopurine, 2' deoxycoformycin, alpha-interferon, etc. (6,13,15). We used vinblastine, prednisolone and endoxan for treating LCH in these monozygotic twins who responded with-out any toxicities. A high correlation between response within 6 weeks and outcome has been reported. Our patients responded early and continue to remain well for 2 years.

Contributors: ABP worked up the case and drafted the paper. RLR performed the literature search.
Funding: None.
Competing interests: None stated.

Key Messages

  • This is a rare presentation (in monozygotic twins) of a rare hematological disorder (Langerhans Cell Histiocytosis)

  • It can be hypothesized that LCH has a genetic predisposition.


 References


1. Kusumakumary P, Priyakumari T, Chellam VG, James FV, Nair MK. Langerhans Cell Histiocytosis in children less than 2 years of age. Indian Pediatr 1999; 36: 29-35.

2. Mahmod H, Wang WC. The Histiocytosis. In: Rudolph’s Pediatrics, 20th edn. Eds. Rudolph AM, Hoffman JIE, Rudolph CD. New Jersey, Prentice Hall, 1996: pp 1302-1306.

3. Bierman HR. Apparent Cure of Letterer-Siwe disease: Seventeen year survival of identical twins with non-lipoid reticuloendotheliosis. JAMA 1966; 19: 156-158.

4. Mader 1, Stock KW, Radue EW, Steinbrich W. Langerhans cell histiocytosis in monozy-gote twins: Case reports. Neuroradiology 1996; 38: 163-165.

5. Kanold J, Vannier JP, Fusade T, Drouin V, Thomine E, Prudent M, et al. Langerhans-cell histiocytosis in twin sisters. Arch Pediatr 1994; 1: 49-53.

6. Halton J, Whitton A, Wiemikowski J, Barr RD. Disseminated Langerhans Cell Histio-cytosis in identical twins unresponsive to recombinant human alpha-interferon and total body irradiation. Am J Pediatr Hematol Oncol 1992; 14: 269-272.

7. Mack TM, Cozen W, Shibata DK, Weiss LM, Nathwani BN, Hernandez AM, et al. Concor-dance for Hodgkin’s disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995; 32: 413-418.

8. Kuwabara S, Takahashi M. Eosinophillic granuloma of the skull in identical twin. Neurol Med Chir 1990; 30: 1043-1046.

9. Katz AM, Rosenthal D, Jakubovic HR, Pai RK, Quinonez GE, Sauder DN. Langerhans cell histiocytosis in monozygotic twins. J Am Acad Dermatol 1991; 24: 32-37.

10. Marsh WL Jr, McCarrick JP, Harlan DM. Sinus histiocytosis with massive lymphadeno-pathy: Occurrence in identical twins with retroperitoneal disease. Arch Pathol Lab Med 1988; 112: 298-301.

11. Arico M, Nichols K, Whitlock JA, Arceci R, Haupt R, Mittler U, et al. Familial clustering of Langerhans cell histiocytosis. Br J Hematol 1999; 1999; 107: 883-888.

12. The French Langerhans Cell Histiocytosis Study Group. A Multicentric retrospective Survey of Langerhans cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996; 75: 17-24.

13. YU-LC, Shenoy S, Ward K. Successful treatment of multisystem Langerhans cell histiocytosis with etoposide. Am J Pediatr Hematol Oncol 1994; 16: 275-277.

14. McCowage GB, Frush DP, Kurtzberg J. Successful treatment of two children with Langerhans cell histiocytosis with 2' deoxyco-formycin. J Pediatr Hematol Oncol 1996; 18: 154-158.

15. Ceci A, de-Terlizzi M, Colella R. Langerhans cell histiocytosis in childhood: Results from the Italian Cooperative AIEOP-CNR X’83 study. Med Pediatr Oncol 1993; 21: 259- 264.

16. Gadner H, Heitger A, Grieois N, Gatterer Menz 1, Ladisch S for DALH X-83 study. Treatment strategy for disseminated Langer-hans cell histiocytosis. Med Pediatr Oncol 1994; 23: 72-80.

17. Berry DH, Gresik MV, Humphrey GB, Starling K, Vietti T, Boyett S. et al. Natural history of Histiocytosis X: A Pediatric Onco-logy Group Study. Med Pediatr Oncol 1986; 14: 1-5.

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription